Srirama S. Venkataraman
Research Subjects
Srirama S. Venkataraman has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandar N. Nacev
Engineering, Promaxo Inc., Oakland, USA
1 shared publication - Aleksandar Nacev
Promaxo Inc., Oakland, CA 94607, USA
1 shared publication - Dang Bich Thuy Le
Promaxo Inc
1 shared publication - Dinesh Kumar
Operations, Promaxo Inc., Oakland, USA
1 shared publication John Adams Jr.
Urology, Mississippi Urology Clinic, PLLC., Jackson, USA
1 shared publication- Joseph N Macaluso
Endourology, LSU Health Foundation, New Orleans, USA
1 shared publication
Latest Publications
- Open Access
- 9 January 2025
- Published by MDPI AG in Bioengineering
- Vol. 12 (1) , 47
Haralick Texture Analysis for Differentiating Suspicious Prostate Lesions from Normal Tissue in Low-Field MRI
This study evaluates the feasibility of using Haralick texture analysis on low-field, T2-weighted MRI images for detecting prostate cancer, extending current research from high-field MRI to the more accessible and cost-effective low-field MRI. A total of twenty-one patients with biopsy-proven prostate cancer (Gleason score 4+3 or higher) were included. Before transperineal biopsy guided by low-field (58–74mT) MRI, a radiologist annotated suspicious regions of interest (ROIs) on high-field (3T) MRI. Rigid image registration was performed to align corresponding regions on both high- and low-field images, ensuring an accurate propagation of annotations to the co-registered low-field images for texture feature calculations. For each cancerous ROI, a matching ROI of identical size was drawn in a non-suspicious region presumed to be normal tissue. Four Haralick texture features (Energy, Correlation, Contrast, and Homogeneity) were extracted and compared between cancerous and non-suspicious ROIs. Two extraction methods were used: the direct computation of texture measures within the ROIs and a sliding window technique generating texture maps across the prostate from which average values were derived. The results demonstrated statistically significant differences in texture features between cancerous and non-suspicious regions. Specifically, Energy and Homogeneity were elevated (p-values: p-values: <0.00001–0.03) in cancerous ROIs. These findings suggest that Haralick texture features are both feasible and informative for differentiating abnormalities, offering promise in assisting prostate cancer detection on low-field MRI.
- 9 January 2025
- Published by MDPI AG in Bioengineering
- Vol. 12 (1) , 47
Open AccessHaralick Texture Analysis for Differentiating Suspicious Prostate Lesions from Normal Tissue in Low-Field MRI
This study evaluates the feasibility of using Haralick texture analysis on low-field, T2-weighted MRI images for detecting prostate cancer, extending current research from high-field MRI to the more accessible and cost-effective low-field MRI. A total of twenty-one patients with biopsy-proven prostate cancer (Gleason score 4+3 or higher) were included. Before transperineal biopsy guided by low-field (58–74mT) MRI, a radiologist annotated suspicious regions of interest (ROIs) on high-field (3T) MRI. Rigid image registration was performed to align corresponding regions on both high- and low-field images, ensuring an accurate propagation of annotations to the co-registered low-field images for texture feature calculations. For each cancerous ROI, a matching ROI of identical size was drawn in a non-suspicious region presumed to be normal tissue. Four Haralick texture features (Energy, Correlation, Contrast, and Homogeneity) were extracted and compared between cancerous and non-suspicious ROIs. Two extraction methods were used: the direct computation of texture measures within the ROIs and a sliding window technique generating texture maps across the prostate from which average values were derived. The results demonstrated statistically significant differences in texture features between cancerous and non-suspicious regions. Specifically, Energy and Homogeneity were elevated (p-values: p-values: <0.00001–0.03) in cancerous ROIs. These findings suggest that Haralick texture features are both feasible and informative for differentiating abnormalities, offering promise in assisting prostate cancer detection on low-field MRI.
- Open Access
- 15 May 2022
- Published by Springer Nature in Cureus
- Vol. 14 (5) , e25021
Office-Based, Single-Sided, Low-Field MRI-Guided Prostate Biopsy
This paper describes the workflow of transperineal prostate biopsy (TBx) using the single-sided, low-field Promaxo MRI system (Promaxo Inc., Oakland, California, United States) operating at a field strength ranging between 58 and 74 millitesla (mT). Prostate cancer (PCa) is the leading cause of cancer-related death and the second most frequently diagnosed cancer in men. Systematic biopsy (SBx) with 12-14 cores is the preferred standard of care procedure. The blinded approach of SBx, however, results in several shortcomings, including high rates of false negatives and increased infection rates due to the transrectal approach. The evolution of clinical use and scientific research using different prostate biopsy modalities is discussed, including the potential for the Promaxo MRI system to mitigate logistical constraints often associated with standard magnetic resonance (MR)-guided biopsy through the utilization of an office-based, low-field MRI.
- 15 May 2022
- Published by Springer Nature in Cureus
- Vol. 14 (5) , e25021
Open AccessOffice-Based, Single-Sided, Low-Field MRI-Guided Prostate Biopsy
This paper describes the workflow of transperineal prostate biopsy (TBx) using the single-sided, low-field Promaxo MRI system (Promaxo Inc., Oakland, California, United States) operating at a field strength ranging between 58 and 74 millitesla (mT). Prostate cancer (PCa) is the leading cause of cancer-related death and the second most frequently diagnosed cancer in men. Systematic biopsy (SBx) with 12-14 cores is the preferred standard of care procedure. The blinded approach of SBx, however, results in several shortcomings, including high rates of false negatives and increased infection rates due to the transrectal approach. The evolution of clinical use and scientific research using different prostate biopsy modalities is discussed, including the potential for the Promaxo MRI system to mitigate logistical constraints often associated with standard magnetic resonance (MR)-guided biopsy through the utilization of an office-based, low-field MRI.